Jordana Zwerling, MA | Psychiatrist.com

Letter to the Editor

Rapastinel (GLYX-13) Effects in OCD

February 21, 2018

Read a study investigating the effects of rapastinel administration on 7 patients with OCD.

Omer Linkovski, Hanyang Shen, Jordana Zwerling, et al

Letter to the Editor

Challenges in Testing Intranasal Ketamine in OCD

April 26, 2017

Reports have indicated that a single intravenous ketamine dose rapidly decreases OCD symptoms. These researchers planned a study of nasal ketamine administration for this purpose, but they quickly encountered...

Carolyn I. Rodriguez, Kyle A. B. Lapidus, Jordana Zwerling, et al

Letter to the Editor

Memantine in OCD

May 25, 2016

Ketamine may reduce OCD symptoms in some patients, but IV administration is undesirable. Learn whether oral memantine, another NMDA receptor antagonist, would be a good alternative.

Carolyn I. Rodriguez, Amanda Levinson, Jordana Zwerling, et al

Letter to the Editor

Can Exposure-Based CBT Extend the Effects of Intravenous Ketamine in Obsessive-Compulsive Disorder? An Open-Label Trial

March 23, 2016

Carolyn I. Rodriguez, Michael Wheaton, Jordana Zwerling, et al